Cell Reports (Mar 2014)

Caspase-11 Controls Interleukin-1β Release through Degradation of TRPC1

  • Bénédicte F. Py,
  • Mingzhi Jin,
  • Bimal N. Desai,
  • Anirudh Penumaka,
  • Hong Zhu,
  • Maike Kober,
  • Alexander Dietrich,
  • Marta M. Lipinski,
  • Thomas Henry,
  • David E. Clapham,
  • Junying Yuan

DOI
https://doi.org/10.1016/j.celrep.2014.02.015
Journal volume & issue
Vol. 6, no. 6
pp. 1122 – 1128

Abstract

Read online

Caspase-11 is a highly inducible caspase that controls both inflammatory responses and cell death. Caspase-11 controls interleukin 1β (IL-1β) secretion by potentiating caspase-1 activation and induces caspase-1-independent pyroptosis downstream of noncanonical NLRP3 inflammasome activators such as lipopolysaccharide (LPS) and Gram-negative bacteria. However, we still know very little about the downstream mechanism of caspase-11 in regulating inflammation because the known substrates of caspase-11 are only other caspases. Here, we identify the cationic channel subunit transient receptor potential channel 1 (TRPC1) as a substrate of caspase-11. TRPC1 deficiency increases the secretion of IL-1β without modulating caspase-1 cleavage or cell death in cultured macrophages. Consistently, trpc1−/− mice show higher IL-1β secretion in the sepsis model of intraperitoneal LPS injection. Altogether, our data suggest that caspase-11 modulates the cationic channel composition of the cell and thus regulates the unconventional secretion pathway in a manner independent of caspase-1.